Here are relevant reports on : continuous-glucose-monitoring-devices-market
-
Blood Glucose Monitoring Devices Market by Product [Blood Glucose Meters, Continuous Glucose Monitoring Systems (Sensors, Transmitter), Glucose Monitoring Strips, Lancets], Application (Hospitals, Diagnostics, Home Settings) - Global Forecasts to 2019
The global blood glucose monitoring devices market is expected to grow at a significantly high rate in the next five years. Global rise in the prevalence and incidence of diabetes and increasing adoption of continuous glucose monitoring (CGM) systems are the key factors propelling the growth of this market. In addition, continuous technological advancements in blood glucose monitoring devices and rapid growth in aging population are further stimulating the demand for blood glucose monitoring devices. However, inadequate reimbursement and high cost associated with the application of CGM systems and product recalls are some of the key factors hampering the growth of this market.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
European Medical Devices Market by Type (Diagnostic Imaging, Endoscopy Equipment, Respiratory Care, Cardiac Monitoring Devices, Haemodialysis Devices, Ophthalmic Devices, Anesthesia Monitoring), End User (Hospitals, Home-care) & Region - Global Forecast to 2025
European medical devices market growth is primed to transition from $48.9 billion in 2020 to $61.4 billion by 2025, showcasing a strong CAGR of 4.7%. Key growth drivers include an aging population, advancements in medical technology, and an increasing number of surgical procedures, alongside the need for cost containment in healthcare.
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
Patient Monitoring Devices Market by Product (Cardiac monitoring devices, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitor, blood pressure monitors, ECG, ICP, weight Monitoring), User, Customer Unmet Needs & Region - Global Forecast to 2029
The global patient monitoring devices market, valued at US$45.7 billion in 2022, stood at US$48.5 billion in 2024 and is projected to advance at a resilient CAGR of 8.0% from 2024 to 2029, culminating in a forecasted valuation of US$71.1 billion by the end of the period. This growth is driven by factors such as the increasing prevalence of chronic disorders, an aging population, advancements in healthcare technology, and the rising adoption of wireless monitoring devices.
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Vital Signs Monitoring Market - Landscape Analysis of Blood Pressure Monitoring Devices, Pulse Oximeters and Temperature Monitoring Devices - Forecasts up to 2018
The word “vital” connotes the most significant requirement for sustaining healthy life. Blood pressure, respiratory rate, heart rate and body temperature within a normal range are necessary for the survival of human life and these parameters are referred to as vital signs.
- Published: August 2013
- Price: $ 4950
- TOC Available:
-
Mercury Analyzer Market by Type (Cold Vapor Atomic Absorption and Cold Vapor Atomic Fluorescence), Monitoring Type (Continuous and Lab), End-Use Industry (Environmental Monitoring, Food Industry) and Region - Global Forecast to 2029
The mercury analyzer market is expected to grow from USD 310 million in 2024 to USD 426 million by 2029, at a compound annual growth rate (CAGR) of 6.6% during the forecast period.The key players Teledyne Leeman Labs (US), Tekran Instruments Corporation (Canada), Thermo Fisher Scientific Inc. (US), PerkinElmer Inc. (US), Milestone Srl (US), Analytik Jena GmbH+Co. KG (Germany), Nippon Instruments Corporation (Japan), Hitachi High-Tech Corporation (Japan), Lumex Instruments (Canada), ENVEA (France).
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) & Region- Global Forecast to 2030
The global in vitro diagnostics market, valued at US$101.05billion in 2024, stood at US$109.06 billion in 2025 and is projected to advance at a resilient CAGR of 7.6% from 2025 to 2030, culminating in a forecasted valuation of US$157.63 billion by the end of the period. Market growth is primarily fueled by the rising prevalence of chronic and infectious diseases, increasing demand for rapid and accurate diagnostic solutions, and the growing shift toward personalized medicine.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Europe In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) - Forecast to 2031
The Europe in vitro diagnostics (IVD) market, valued at USD 31.43 billion in 2025, stood at USD 33.83 billion in 2026 and is projected to advance at a resilient CAGR of 7.9% from 2026 to 2031, culminating in a forecasted valuation of USD 49.49 billion by the end of the period. Market growth is driven by rising diagnostic test volumes across national healthcare systems, broader adoption of population-based screening programs, and increasing emphasis on standardized disease monitoring.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Medical Wearables Market by Device (Vital Signs Monitoring, Blood Pressure Monitor, Glucose Monitor, ECG Monitor, Pulse Oximeter), Product (Smartwatch, Patches, Wristbands), End User (Hospitals, Nursing Homes, Ambulatory) & Region - Global Forecast to 2025
The global medical wearables market in terms of revenue was estimated to be worth $7.4 billion in 2020 and is poised to reach $19.5 billion by 2025, growing at a CAGR of 21.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
US In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) - Forecast to 2031
US In Vitro Diagnostics market, valued at USD 37.43 billion in 2025, stood at USD 40.15 billion in 2026 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2031, culminating in a forecasted valuation of USD 57.18 billion by the end of the period. This growth is primarily driven by the rising prevalence of chronic and infectious diseases, the increasing demand for early and accurate diagnostic testing, the widespread adoption of advanced molecular diagnostic technologies, the growth in point-of-care testing, and continuous innovations in diagnostic instruments and assays.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Remote Patient Monitoring (RPM) Market by Offering (Software, integrated device), Device (Wearable, implants, handheld), Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End user, & Region - Global Forecast to 2030
The global remote patient monitoring market, valued at US$24.39B in 2023, is forecasted to grow at a 12.7% CAGR, reaching US$27.72B by 2024 and US$56.94B by 2030. The key drivers behind this growth include increasing chronic diseases, home healthcare preferences, advances in wearable technology, and the digital transformation of healthcare.
- Published: February 2025
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
